Changes in Provider Treatment Patterns for Dupuytren’s Contracture: Analysis of Trends in Medicare Beneficiaries

BACKGROUND: Collagenase Clostridium histolyticum (CCH) injection has been shown to be a safe and effective treatment option for Dupuytren’s contracture. We hypothesize that the gaining popularity of CCH has resulted in a change in treatment patterns among providers, with increased utilization of CCH...

Descripción completa

Detalles Bibliográficos
Autores principales: Thayer, Mary Kate, Somerson, Jeremy S., Huang, Jerry I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250467/
https://www.ncbi.nlm.nih.gov/pubmed/30534492
http://dx.doi.org/10.1097/GOX.0000000000001932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250467/
https://www.ncbi.nlm.nih.gov/pubmed/30534492
http://dx.doi.org/10.1097/GOX.0000000000001932

Ejemplares similares